{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:53:23Z","timestamp":1792634003015,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 NS104573"],"award-info":[{"award-number":["R01 NS104573"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 NS104573"],"award-info":[{"award-number":["R01 NS104573"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"crossref","award":["BX000347"],"award-info":[{"award-number":["BX000347"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"crossref","award":["BX000891"],"award-info":[{"award-number":["BX000891"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Post-stroke cognitive impairment (PSCI) is a major source of disability, affecting up to two thirds of stroke survivors with no available therapeutic options. The condition remains understudied in preclinical models due to its delayed presentation. Although hypertension is a leading risk factor for dementia, how ischemic stroke contributes to this neurodegenerative condition is unknown. In this study, we used a model of hypertension to study the development of PSCI and its mechanisms. Spontaneously hypertensive rats (SHR) were compared to normotensive rats and were subjected to 1-h middle cerebral artery occlusion or sham surgery. Novel object recognition, passive avoidance test and Morris water maze were used to assess cognition. In addition, brain magnetic resonance images were obtained 12-weeks post-stroke and tissue was collected for immunohistochemistry and protein quantification. Stroked animals developed impairment in long-term memory at 4-weeks post-stroke despite recovery from motor deficits, with hypertensive animals showing some symptoms of anhedonia. Stroked SHRs displayed grey matter atrophy and had a two-fold increase in apoptosis in the ischemic borderzone and increased markers of inflammatory cell death and DNA damage at 12\u00a0weeks post-stroke. This indicates that preexisting hypertension exacerbates the development of secondary neurodegeneration after stroke beyond its acute effects on neurovascular injury.<\/jats:p>","DOI":"10.1038\/s41598-020-75450-6","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T11:03:51Z","timestamp":1605783831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Stroke promotes the development of brain atrophy and delayed cell death in hypertensive rats"],"prefix":"10.1038","volume":"10","author":[{"given":"Mohammed A.","family":"Sayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Eldahshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Abdelbary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindu","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Althomali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribeth H.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali S.","family":"Arbab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adviye","family":"Ergul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"issue":"12","key":"75450_CR1","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","volume":"137","author":"EJ Benjamin","year":"2018","unstructured":"Benjamin, E. J. et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation 137(12), e67\u2013e492 (2018).","journal-title":"Circulation"},{"issue":"8","key":"75450_CR2","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1161\/STROKEAHA.111.621904","volume":"42","author":"A Towfighi","year":"2011","unstructured":"Towfighi, A. & Saver, J. L. Stroke declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead. Stroke 42(8), 2351\u20132355 (2011).","journal-title":"Stroke"},{"issue":"8","key":"75450_CR3","first-page":"80","volume":"2","author":"JH Sun","year":"2014","unstructured":"Sun, J. H., Tan, L. & Yu, J. T. Post-stroke cognitive impairment: epidemiology, mechanisms and management. Ann. Transl Med. 2(8), 80 (2014).","journal-title":"Ann. Transl Med."},{"key":"75450_CR4","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.2741\/2776","volume":"13","author":"J Woitzik","year":"2008","unstructured":"Woitzik, J., Back, T. & Thome, C. Flow-dependent versus spreading-like impairment of brain tissue integrity during focal cerebral ischemia and its consequences for neuroprotective strategies. Front. Biosci. 13, 1500\u20131506 (2008).","journal-title":"Front. Biosci."},{"issue":"11","key":"75450_CR5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S1474-4422(05)70221-0","volume":"4","author":"D Leys","year":"2005","unstructured":"Leys, D. et al. Poststroke dementia. Lancet Neurol 4(11), 752\u2013759 (2005).","journal-title":"Lancet Neurol"},{"key":"75450_CR6","doi-asserted-by":"crossref","unstructured":"Obaid, M., et al. Long-Term Outcomes in Stroke Patients with Cognitive Impairment: A Population-Based Study. Geriatrics (Basel), 2020. 5(2).","DOI":"10.3390\/geriatrics5020032"},{"issue":"6","key":"75450_CR7","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1161\/STROKEAHA.110.579888","volume":"41","author":"ST Pendlebury","year":"2010","unstructured":"Pendlebury, S. T. et al. Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke 41(6), 1290\u20131293 (2010).","journal-title":"Stroke"},{"issue":"4","key":"75450_CR8","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s00415-009-5387-9","volume":"257","author":"A Bour","year":"2010","unstructured":"Bour, A. et al. How predictive is the MMSE for cognitive performance after stroke?. J. Neurol. 257(4), 630\u2013637 (2010).","journal-title":"J. Neurol."},{"issue":"1","key":"75450_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/1747493016666091","volume":"13","author":"F Arba","year":"2018","unstructured":"Arba, F. et al. Enlarged perivascular spaces and cognitive impairment after stroke and transient ischemic attack. Int. J. Stroke 13(1), 47\u201356 (2018).","journal-title":"Int. J. Stroke"},{"issue":"3","key":"75450_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/ane.12709","volume":"136","author":"H Delavaran","year":"2017","unstructured":"Delavaran, H. et al. Cognitive function in stroke survivors: A 10-year follow-up study. Acta Neurol. Scand 136(3), 187\u2013194 (2017).","journal-title":"Acta Neurol. Scand"},{"issue":"2","key":"75450_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40263-015-0230-6","volume":"29","author":"L Rouch","year":"2015","unstructured":"Rouch, L. et al. Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms. CNS Drugs 29(2), 113\u2013130 (2015).","journal-title":"CNS Drugs"},{"issue":"11","key":"75450_CR12","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/jcbfm.2013.159","volume":"33","author":"M Wiesmann","year":"2013","unstructured":"Wiesmann, M., Kiliaan, A. J. & Claassen, J. A. Vascular aspects of cognitive impairment and dementia. J. Cereb. Blood Flow Metab. 33(11), 1696\u20131706 (2013).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"75450_CR13","doi-asserted-by":"crossref","unstructured":"Filipska, K., et al. Are depression and dementia a common problem for stroke older adults? A review of chosen epidemiological studies. Psychiatr Q, 2020.","DOI":"10.1007\/s11126-020-09734-5"},{"issue":"1","key":"75450_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3233\/JAD-2008-14110","volume":"14","author":"KA Jellinger","year":"2008","unstructured":"Jellinger, K. A. The pathology of \u201cvascular dementia\u201d: a critical update. J. Alzheimers Dis. 14(1), 107\u2013123 (2008).","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"75450_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1747-4949.2011.00731.x","volume":"7","author":"R Sahathevan","year":"2012","unstructured":"Sahathevan, R., Brodtmann, A. & Donnan, G. A. Dementia, stroke, and vascular risk factors; a review. Int. J. Stroke 7(1), 61\u201373 (2012).","journal-title":"Int. J. Stroke"},{"issue":"9735","key":"75450_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(10)60975-0","volume":"376","author":"JV Tu","year":"2010","unstructured":"Tu, J. V. Reducing the global burden of stroke: INTERSTROKE. Lancet 376(9735), 74\u201375 (2010).","journal-title":"Lancet"},{"issue":"8","key":"75450_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S1474-4422(05)70141-1","volume":"4","author":"C Qiu","year":"2005","unstructured":"Qiu, C., Winblad, B. & Fratiglioni, L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 4(8), 487\u2013499 (2005).","journal-title":"Lancet Neurol."},{"issue":"1","key":"75450_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1161\/01.HYP.0000168052.00426.65","volume":"46","author":"MF O'Rourke","year":"2005","unstructured":"O\u2019Rourke, M. F. & Safar, M. E. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 46(1), 200\u2013204 (2005).","journal-title":"Hypertension"},{"issue":"2","key":"75450_CR19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1001\/archneur.63.2.246","volume":"63","author":"R Au","year":"2006","unstructured":"Au, R. et al. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch. Neurol. 63(2), 246\u2013250 (2006).","journal-title":"Arch. Neurol."},{"issue":"11","key":"75450_CR20","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1212\/WNL.56.11.1539","volume":"56","author":"JC de Groot","year":"2001","unstructured":"de Groot, J. C. et al. Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology 56(11), 1539\u20131545 (2001).","journal-title":"Neurology"},{"issue":"1","key":"75450_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12974-018-1262-x","volume":"15","author":"HA Ahmed","year":"2018","unstructured":"Ahmed, H. A. et al. RAS modulation prevents progressive cognitive impairment after experimental stroke: a randomized, blinded preclinical trial. J. Neuroinflamm. 15(1), 229\u2013229 (2018).","journal-title":"J. Neuroinflamm."},{"issue":"3","key":"75450_CR22","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1124\/jpet.108.139618","volume":"326","author":"W Kozak","year":"2008","unstructured":"Kozak, W. et al. Vascular protection with candesartan after experimental acute stroke in hypertensive rats: a dose-response study. J. Pharmacol. Exp. Ther. 326(3), 773\u2013782 (2008).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"75450_CR23","doi-asserted-by":"publisher","first-page":"H1192","DOI":"10.1152\/ajpheart.00446.2018","volume":"316","author":"W Eldahshan","year":"2019","unstructured":"Eldahshan, W. et al. Angiotensin II type 2 receptor stimulation with compound 21 improves neurological function after stroke in female rats: a pilot study. Am. J. Physiol. Heart Circ. Physiol. 316(5), H1192-h1201 (2019).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"75450_CR24","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.bbr.2018.10.010","volume":"359","author":"HA Ahmed","year":"2019","unstructured":"Ahmed, H. A. et al. Angiotensin receptor (AT2R) agonist C21 prevents cognitive decline after permanent stroke in aged animals-A randomized double- blind pre-clinical study. Behav. Brain Res. 359, 560\u2013569 (2019).","journal-title":"Behav. Brain Res."},{"key":"75450_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbr.2017.12.007","volume":"346","author":"HA Ahmed","year":"2018","unstructured":"Ahmed, H. A. et al. Role of angiotensin system modulation on progression of cognitive impairment and brain MRI changes in aged hypertensive animals - A randomized double- blind pre-clinical study. Behav. Brain Res. 346, 29\u201340 (2018).","journal-title":"Behav. Brain Res."},{"key":"75450_CR26","doi-asserted-by":"crossref","unstructured":"Jackson, L., et al. Delayed administration of Angiotensin II Type 2 receptor (AT2R) agonist compound 21 prevents the development of post-stroke cognitive impairment in diabetes through the modulation of microglia polarization. Transl Stroke Res. 2019.","DOI":"10.1007\/s12975-019-00752-5"},{"issue":"4","key":"75450_CR27","doi-asserted-by":"publisher","first-page":"e60625","DOI":"10.1371\/journal.pone.0060625","volume":"8","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Comparison of invasive blood pressure measurements from the caudal ventral artery and the femoral artery in male adult SD and Wistar rats. PLoS ONE 8(4), e60625 (2013).","journal-title":"PLoS ONE"},{"issue":"3","key":"75450_CR28","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ajpath.2010.12.004","volume":"178","author":"X Ba","year":"2011","unstructured":"Ba, X. & Garg, N. J. Signaling mechanism of poly(ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases. Am. J. Pathol. 178(3), 946\u2013955 (2011).","journal-title":"Am. J. Pathol."},{"issue":"21","key":"75450_CR29","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1016\/j.febslet.2012.09.026","volume":"586","author":"P Bai","year":"2012","unstructured":"Bai, P. & Virag, L. Role of poly(ADP-ribose) polymerases in the regulation of inflammatory processes. FEBS Lett. 586(21), 3771\u20133777 (2012).","journal-title":"FEBS Lett."},{"issue":"14","key":"75450_CR30","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.1073\/pnas.0306895101","volume":"101","author":"HC Ha","year":"2004","unstructured":"Ha, H. C. Defective transcription factor activation for proinflammatory gene expression in poly(ADP-ribose) polymerase 1-deficient glia. Proc. Natl. Acad. Sci. USA 101(14), 5087\u20135092 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"75450_CR31","doi-asserted-by":"publisher","first-page":"H1115","DOI":"10.1152\/ajpheart.00349.2015","volume":"309","author":"GS Masson","year":"2015","unstructured":"Masson, G. S. et al. Aerobic training normalizes autonomic dysfunction, HMGB1 content, microglia activation and inflammation in hypothalamic paraventricular nucleus of SHR. Am. J. Physiol. Heart Circ. Physiol. 309(7), H1115\u2013H1122 (2015).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7\u20138","key":"75450_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.neurol.2017.06.009","volume":"173","author":"M Barbay","year":"2017","unstructured":"Barbay, M. et al. Vascular cognitive impairment: advances and trends. Rev. Neurol. (Paris) 173(7\u20138), 473\u2013480 (2017).","journal-title":"Rev. Neurol. (Paris)"},{"issue":"5","key":"75450_CR33","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.bbadis.2016.01.015","volume":"1862","author":"RN Kalaria","year":"2016","unstructured":"Kalaria, R. N., Akinyemi, R. & Ihara, M. Stroke injury, cognitive impairment and vascular dementia. Biochim. Biophys. Acta 1862(5), 915\u2013925 (2016).","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"75450_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jama.2015.6968","volume":"314","author":"DA Levine","year":"2015","unstructured":"Levine, D. A. et al. Trajectory of cognitive decline after incident stroke. JAMA 314(1), 41\u201351 (2015).","journal-title":"JAMA"},{"issue":"1","key":"75450_CR35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/HYPERTENSIONAHA.113.02189","volume":"63","author":"K Ishitsuka","year":"2014","unstructured":"Ishitsuka, K. et al. High blood pressure after acute ischemic stroke is associated with poor clinical outcomes: Fukuoka Stroke Registry. Hypertension 63(1), 54\u201360 (2014).","journal-title":"Hypertension"},{"issue":"4","key":"75450_CR36","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12975-016-0464-8","volume":"7","author":"A Ergul","year":"2016","unstructured":"Ergul, A. et al. Impact of comorbidities on acute injury and recovery in preclinical stroke research: focus on hypertension and diabetes. Transl Stroke Res. 7(4), 248\u2013260 (2016).","journal-title":"Transl Stroke Res."},{"key":"75450_CR37","doi-asserted-by":"crossref","unstructured":"Nam, H., et al. Learned helplessness and social avoidance in the Wistar-Kyoto rat. 2014. 8(109).","DOI":"10.3389\/fnbeh.2014.00109"},{"key":"75450_CR38","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.bbr.2019.03.011","volume":"365","author":"C Zorzo","year":"2019","unstructured":"Zorzo, C. et al. Adult social isolation leads to anxiety and spatial memory impairment: Brain activity pattern of COx and c-Fos. Behav. Brain Res. 365, 170\u2013177 (2019).","journal-title":"Behav. Brain Res."},{"issue":"3","key":"75450_CR39","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.09.037","volume":"24","author":"S Kono","year":"2015","unstructured":"Kono, S. et al. Neurovascular protection by telmisartan via reducing neuroinflammation in stroke-resistant spontaneously hypertensive rat brain after ischemic stroke. J. Stroke Cerebrovasc. Dis. 24(3), 537\u2013547 (2015).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"6","key":"75450_CR40","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.12.051","volume":"23","author":"K Sato","year":"2014","unstructured":"Sato, K. et al. Telmisartan reduces progressive oxidative stress and phosphorylated alpha-synuclein accumulation in stroke-resistant spontaneously hypertensive rats after transient middle cerebral artery occlusion. J. Stroke Cerebrovasc. Dis. 23(6), 1554\u20131563 (2014).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"1\u20132","key":"75450_CR41","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/0006-8993(88)91574-0","volume":"450","author":"S Ritter","year":"1988","unstructured":"Ritter, S. et al. Cerebroventricular dilation in spontaneously hypertensive rats (SHRs) is not attenuated by reduction of blood pressure. Brain Res. 450(1\u20132), 354\u2013359 (1988).","journal-title":"Brain Res."},{"issue":"6","key":"75450_CR42","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1124\/mol.59.6.1497","volume":"59","author":"R Halmosi","year":"2001","unstructured":"Halmosi, R. et al. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system. Mol. Pharmacol. 59(6), 1497\u20131505 (2001).","journal-title":"Mol. Pharmacol."},{"issue":"5\u20136","key":"75450_CR43","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s10495-020-01600-w","volume":"25","author":"WH Li","year":"2020","unstructured":"Li, W. H. et al. Baicalein attenuates caspase-independent cells death via inhibiting PARP-1 activation and AIF nuclear translocation in cerebral ischemia\/reperfusion rats. Apoptosis 25(5\u20136), 354\u2013369 (2020).","journal-title":"Apoptosis"},{"issue":"3","key":"75450_CR44","doi-asserted-by":"publisher","first-page":"e0174401","DOI":"10.1371\/journal.pone.0174401","volume":"12","author":"K Eros","year":"2017","unstructured":"Eros, K. et al. Chronic PARP-1 inhibition reduces carotid vessel remodeling and oxidative damage of the dorsal hippocampus in spontaneously hypertensive rats. PLoS ONE 12(3), e0174401 (2017).","journal-title":"PLoS ONE"},{"issue":"1","key":"75450_CR45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0006-8993(03)03362-6","volume":"989","author":"VC Besson","year":"2003","unstructured":"Besson, V. C. et al. Deleterious poly(ADP-ribose)polymerase-1 pathway activation in traumatic brain injury in rat. Brain Res. 989(1), 58\u201366 (2003).","journal-title":"Brain Res."},{"key":"75450_CR46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.intimp.2018.04.043","volume":"60","author":"MY Noh","year":"2018","unstructured":"Noh, M. Y. et al. Regulatory T cells increase after treatment with poly (ADP-ribose) polymerase-1 inhibitor in ischemic stroke patients. Int. Immunopharmacol. 60, 104\u2013110 (2018).","journal-title":"Int. Immunopharmacol."},{"key":"75450_CR47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fncel.2016.00056","volume":"10","author":"RJ Turner","year":"2016","unstructured":"Turner, R. J. & Sharp, F. R. Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke. Front. Cell Neurosci. 10, 56 (2016).","journal-title":"Front. Cell Neurosci."},{"issue":"7","key":"75450_CR48","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1161\/STROKEAHA.120.029395","volume":"51","author":"L Mechtouff","year":"2020","unstructured":"Mechtouff, L. et al. Matrix metalloproteinase-9 and monocyte chemoattractant protein-1 are associated with collateral status in acute ischemic stroke with large vessel occlusion. Stroke 51(7), 2232\u20132235 (2020).","journal-title":"Stroke"},{"issue":"2","key":"75450_CR49","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.01.025","volume":"27","author":"Y Gao","year":"2018","unstructured":"Gao, Y. et al. Effect of telmisartan on preventing learning and memory deficits via peroxisome proliferator-activated receptor-gamma in vascular dementia spontaneously hypertensive rats. J. Stroke Cerebrovasc. Dis. 27(2), 277\u2013285 (2018).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"75450_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1478-811X-8-31","volume":"8","author":"GV Chaitanya","year":"2010","unstructured":"Chaitanya, G. V., Steven, A. J. & Babu, P. P. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun. Signal. 8, 31 (2010).","journal-title":"Cell Commun. Signal."},{"issue":"3","key":"75450_CR51","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.neuroscience.2008.06.025","volume":"158","author":"E Candelario-Jalil","year":"2009","unstructured":"Candelario-Jalil, E., Yang, Y. & Rosenberg, G. A. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 158(3), 983\u2013994 (2009).","journal-title":"Neuroscience"},{"issue":"Pt 3","key":"75450_CR52","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/brain\/124.3.493","volume":"124","author":"RN Mandler","year":"2001","unstructured":"Mandler, R. N. et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic\u2019s neuromyelitis optica. Brain 124(Pt 3), 493\u2013498 (2001).","journal-title":"Brain"},{"issue":"4","key":"75450_CR53","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.bbrc.2009.07.080","volume":"387","author":"AC Nicolescu","year":"2009","unstructured":"Nicolescu, A. C. et al. Inhibition of matrix metalloproteinase-2 by PARP inhibitors. Biochem. Biophys. Res. Commun. 387(4), 646\u2013650 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"75450_CR54","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s13104-015-1284-8","volume":"8","author":"J Christensen","year":"2015","unstructured":"Christensen, J. & Shastri, V. P. Matrix-metalloproteinase-9 is cleaved and activated by cathepsin K. BMC Res. Notes 8, 322 (2015).","journal-title":"BMC Res. Notes"},{"issue":"31","key":"75450_CR55","doi-asserted-by":"publisher","first-page":"51817","DOI":"10.18632\/oncotarget.15545","volume":"8","author":"J Bi","year":"2017","unstructured":"Bi, J. et al. Critical role of matrix metallopeptidase 9 in postoperative cognitive dysfunction and age-dependent cognitive decline. Oncotarget 8(31), 51817\u201351829 (2017).","journal-title":"Oncotarget"},{"issue":"5425","key":"75450_CR56","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.285.5425.248","volume":"285","author":"H Wang","year":"1999","unstructured":"Wang, H. et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285(5425), 248\u2013251 (1999).","journal-title":"Science"},{"issue":"7\u20138","key":"75450_CR57","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2119\/2008-00034.Klune","volume":"14","author":"JR Klune","year":"2008","unstructured":"Klune, J. R. et al. HMGB1: endogenous danger signaling. Mol. Med. 14(7\u20138), 476\u2013484 (2008).","journal-title":"Mol. Med."},{"issue":"3","key":"75450_CR58","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1523\/JNEUROSCI.3732-10.2011","volume":"31","author":"HM Gao","year":"2011","unstructured":"Gao, H. M. et al. HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. J. Neurosci. 31(3), 1081\u20131092 (2011).","journal-title":"J. Neurosci."},{"key":"75450_CR59","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3389\/fnins.2018.00628","volume":"12","author":"YN Paudel","year":"2018","unstructured":"Paudel, Y. N. et al. HMGB1: a common biomarker and potential target for TBI, neuroinflammation, epilepsy, and cognitive dysfunction. Front Neurosci. 12, 628 (2018).","journal-title":"Front Neurosci."},{"key":"75450_CR60","doi-asserted-by":"crossref","first-page":"3929438","DOI":"10.1155\/2020\/3929438","volume":"2020","author":"BM Famakin","year":"2020","unstructured":"Famakin, B. M. et al. HMGB1 is a potential mediator of astrocytic TLR4 signaling activation following acute and chronic focal cerebral ischemia. Neurol. Res. Int. 2020, 3929438 (2020).","journal-title":"Neurol. Res. Int."},{"issue":"12","key":"75450_CR61","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1089\/ars.2015.6397","volume":"24","author":"V Singh","year":"2016","unstructured":"Singh, V. et al. HMGB1 as a key mediator of immune mechanisms in ischemic stroke. Antioxid Redox Signal 24(12), 635\u2013651 (2016).","journal-title":"Antioxid Redox Signal"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75450-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75450-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75450-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T19:13:51Z","timestamp":1697138031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75450-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["75450"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-75450-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]},"assertion":[{"value":"2 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20233"}}